![Paul Goode](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Goode
Technik-/Wissenschafts-/F&E-Leiter bei
GLUCOTRACK, INC.
Vermögen: 108 $ am 30.06.2026
Profil
Paul V.
Goode is currently Director & Chief Technology Officer at GlucoTrack, Inc. since 2026.
Former positions include Director at Elira, Inc. and A.D.
Integrity Applications Ltd., Engineering Director at Impulse Dynamics (USA), Inc. from 2004 to 2006, Engineering Director at DexCom, Inc. from 2001 to 2004, Principal at Guidant Corp.
and Intermedics, Inc., Senior Engineer at MiniMed, Inc., Senior Vice President-Research & Development at EndoStim, Inc. from 2010 to 2019, Vice President-Research & Development at MetaCure (USA), Inc. from 2006 to 2010, and Vice President-Product Development at Orchestra BioMed, Inc. Education includes undergraduate, graduate, and doctorate degrees from North Carolina State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GLUCOTRACK INC 0.01% | 17.07.2026 | 339 ( 0.01% ) | 108 $ | 30.06.2026 |
Aktive Positionen von Paul Goode
| Unternehmen | Position | Beginn |
|---|---|---|
| GLUCOTRACK, INC. | Technik-/Wissenschafts-/F&E-Leiter | 14.07.2026 |
Ehemalige bekannte Positionen von Paul Goode
| Unternehmen | Position | Ende |
|---|---|---|
| ENDOSTIM INC | Vorstandsvorsitzender | 01.07.2019 |
MetaCure (USA), Inc.
 MetaCure (USA), Inc. Pharmaceuticals: MajorHealth Technology Provides invasive treatment for diabetes | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2010 |
Impulse Dynamics (USA), Inc.
 Impulse Dynamics (USA), Inc. Medical SpecialtiesHealth Technology Develops implantable device for the treatment of chronic heart failure | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2006 |
| DEXCOM, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2004 |
A.D. Integrity Applications Ltd.
 A.D. Integrity Applications Ltd. Medical SpecialtiesHealth Technology Develops a non-invasive glucose monitoring device | Direktor/Vorstandsmitglied | - |
Ausbildung von Paul Goode
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
24
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Guidant Corp.
 Guidant Corp. Medical SpecialtiesHealth Technology Develops cardiovascular medical products | Health Technology |
MiniMed, Inc.
 MiniMed, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures, and distributes advanced infusion systems | Health Technology |
EndoStim, Inc.
 EndoStim, Inc. Medical SpecialtiesHealth Technology Develops electro medical devices to treat gastrointestinal neuromuscular disorders | Health Technology |
GlucoTrack, Inc.
 GlucoTrack, Inc. Medical SpecialtiesHealth Technology Develops a non-invasive glucose monitoring device | Health Technology |
DexCom, Inc.
 DexCom, Inc. Medical SpecialtiesHealth Technology Designs, develops and commercializes continuous glucose monitoring systems for management of diabetes & metabolic health by patients, caregivers and clinicians | Health Technology |
North Carolina State University
 North Carolina State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MetaCure (USA), Inc.
MetaCure (USA), Inc. Pharmaceuticals: MajorHealth Technology Provides invasive treatment for diabetes | Health Technology |
Intermedics, Inc.
 Intermedics, Inc. Medical SpecialtiesHealth Technology Develops and markets complex devices for treating malfunctions of the heart | Health Technology |
Elira, Inc.
 Elira, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
A.D. Integrity Applications Ltd.
A.D. Integrity Applications Ltd. Medical SpecialtiesHealth Technology Develops a non-invasive glucose monitoring device | Health Technology |
Orchestra BioMed, Inc.
 Orchestra BioMed, Inc. Medical SpecialtiesHealth Technology Develops transformative therapeutic products | Health Technology |
Impulse Dynamics (USA), Inc.
Impulse Dynamics (USA), Inc. Medical SpecialtiesHealth Technology Develops implantable device for the treatment of chronic heart failure | Health Technology |
